Navigation Links
IDM Pharma Announces Updated Phase 2 UVIDEM(R) Results Showing Durable Disease Control and Tolerability in Advanced Melanoma Patients
Date:11/2/2007

M study and the potential for UVIDEM as a treatment for melanoma. Actual results may differ materially from the forward-looking statements due to a number of important factors, including, but not limited to, whether the Company or any of its collaborators will be able to develop pharmaceutical products using the technologies of the Company, whether clinical trial results to date are predictive of results of any future clinical trials, risks associated with completing clinical trials of product candidates, risks involved in the regulatory approval process for the Company's product candidates, the possibility that clinical testing may reveal undesirable and unintended side effects or other characteristics that may prevent or limit the commercial use of proposed products; whether the cash resources of the Company will be sufficient to fund operations as planned, including any further clinical trials of any of the Company's product candidates, and the Company's dependence on intellectual property. These factors and others affecting the Company's business are more fully discussed in the Company's Annual Report on Form 10-Q filed with the SEC for the quarter ended June 30, 2007 and other periodic reports filed with the SEC. The Company expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law.


'/>"/>
SOURCE IDM Pharma, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Sygnis Pharma AG announces date for presentation of clinical results
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... TUCSON, Ariz. , Aug. 20, 2014 /PRNewswire/ ... of the  Roche  Group, today announced that its ... been CE marked in the European Union for ... specimens. The system, consisting of VENTANA Virtuoso software ... the VENTANA iScan HT slide scanner, provides automated ...
(Date:8/20/2014)... Aug. 20, 2014  Amerigen Pharmaceuticals Ltd. announces that ... has received Chinese FDA (CFDA) approval and has ... into the China domestic ... distribution agreement with Sinochem Jiangsu Pharmaceutical Co., Ltd., ... FDA approved and China CFDA certified oral solid ...
(Date:8/20/2014)... 20, 2014 Reportlinker.com announces that a ... catalogue: The Market for Medical Devices ... The European, Middle Eastern and African markets represent ... part of its coverage, this study: The Market ... EMEA medical device markets and estimates markets for ...
Breaking Medicine Technology:Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 2Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 3Amerigen Pharmaceuticals Ltd. announces that its Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., has received Chinese FDA (CFDA) approval and has subsequently launched its generic Mecobalamin 0.5 mg Tablets into the China domestic mark 2The Market for Medical Devices in EMEA 2The Market for Medical Devices in EMEA 3The Market for Medical Devices in EMEA 4The Market for Medical Devices in EMEA 5
...   " The   Obama administration will ... urban counterparts in adopting technology to improve healthcare quality." ... online health records . " What ... national healthcare IT programmes and initiatives are currently taking place across ...
... WHITE PLAINS, N.Y., Aug. 19, 2011 Today the ... to treat two types of rare blood cancers – ... (Logo: http://photos.prnewswire.com/prnh/20110215/NY48642LOGO) The drug is approved ... cell transplant or two chemotherapy treatments and for ALCL ...
Cached Medicine Technology:Innovations in E-Health & Informatics Europe: The Need for a European EHealth Strategy 2The Leukemia & Lymphoma Society Available to Comment on FDA Approval of Seattle Genetics' Adcetris, First New Treatment for Hodgkin Lymphoma Since 1977 2
(Date:8/20/2014)... 21, 2014 Medical Alert Systems, ... reviews of some of the most popular medical alert ... to announce that it is now offering special deals ... who are on a fixed income but would like ... comes as very welcome news. , As a company ...
(Date:8/20/2014)... August 21, 2014 iFitDress.com, the well-known ... range of cheap evening gowns . All ... of them are priced under $100. , iFitDress.com ... market. It keeps trying its best to help clients ... all its members are kind and professional. According to ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 Today, ... announced the publication of a new eBook, Affordable ... many small business owners feel uncertain about how ... family, and their bottom line. , The new ... and helps businesses navigate their upcoming health insurance ...
(Date:8/20/2014)... Dennis Thompson HealthDay Reporter ... birth rates fell dramatically during the past two decades, plummeting ... government report shows. An estimated 4 million fewer births ... to researchers from the U.S. Centers for Disease Control and ... me from the report," said Bill Albert, chief program officer ...
(Date:8/20/2014)... An imaging study of chronic users of codeine-containing ... regions of brain white matter and associates these ... , Researchers used diffusuion tensor imaging (DTI) (an ... investigate the white matter integrity of chronic CCS ... the brain, including the inferior fronto-occipital fasciculus, which ...
Breaking Medicine News(10 mins):Health News:Medical Alert Systems Website Now Offering Special Prices on the Popular Medical Guardian Product 2Health News:Medical Alert Systems Website Now Offering Special Prices on the Popular Medical Guardian Product 3Health News:iFitDress.com Releases a New Range of Cheap Evening Gowns 2Health News:Teen Birth Rate Has Dropped Dramatically in Last Two Decades: CDC 2Health News:Teen Birth Rate Has Dropped Dramatically in Last Two Decades: CDC 3
... Osteoarthritis is commonly diagnosed in the late and irreversible ... pain and slow progression of disease. Because osteoarthritis is ... and veterinarians need a precise way to diagnose the ... are investigating potential biomarkers in dogs for early diagnosis ...
... , -- New Tissue Dissection System Used by Italian Surgeons ... , PALO ALTO, Calif., June 10 PEAK Surgical, ... System by surgeons in the European Union, where the innovative ... , , Dr. Raul Pellini and Prof. Giuseppe Spriano, ...
... House will help eliminate barriers that discourage doctors from ... 10 Late yesterday U.S. Senators Arlen Specter (PA) ... access to life-saving diagnostic tests for patients who might ... Tests Act (S. 1220) will eliminate the complicated Medicare ...
... Canadian Hospital Specialties, to release EchoStim(R) and EchoBlock(R) ... CINCINNATI, June 10 Havel,s Incorporated, a Cincinnati-based ... CHS, Canadian Hospital Specialties, which will become the ... Needles throughout Canada. , , Canadian Hospital ...
... to Program Would Increase Threat of Disease , , PHILADELPHIA, ... Protection Secretary John Hanger today asked Pennsylvanians to make every effort ... Virus. , , Hanger said standing water can quickly become ... the simple rule of dump it, drain it and treat it. ...
... WALTHAM, Mass., June 10 Millennium Research Group (MRG), ... that despite the economic downturn, market growth in the ... increased colorectal cancer (CRC) screening programs in France, Germany, ... released European Markets for GI Endoscopy Devices 2009 ...
Cached Medicine News:Health News:Early detection of osteoarthritis in dogs could open doors for a cure 2Health News:PEAK Surgical Announces First Use of PEAK PlasmaBlade(TM) in Europe 2Health News:PEAK Surgical Announces First Use of PEAK PlasmaBlade(TM) in Europe 3Health News:PEAK Surgical Announces First Use of PEAK PlasmaBlade(TM) in Europe 4Health News:Legislation Will Expand Access to Life-Saving Laboratory Tests 2Health News:Havel's Incorporated Expands Successful EchoStim(R) Ultrasound Needles into Canada 2Health News:DEP Asks Pennsylvanians to Help Battle West Nile Virus 2Health News:DEP Asks Pennsylvanians to Help Battle West Nile Virus 3Health News:Screening Programs to Drive European GI Videoscope Market Despite Economic Downturn, According to Millennium Research Group 2Health News:Screening Programs to Drive European GI Videoscope Market Despite Economic Downturn, According to Millennium Research Group 3
... An APTT-based kit for the screening of ... specificity of the test for the factor ... sample plasma with an excess of V-DEF ... possible to discriminate between heterozygous and homozygous ...
Inquire...
Inquire...
... remarkable anti-reflux valve is enclosed ... which prevents the valve from ... in sitting or reclining positions. ... and interference free ensuring uninterrupted ...
Medicine Products: